Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Froeling

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
ESMO Open|April 12, 2021
Increasing the human chorionic gonadotrophin cut-off to ≤1000 IU/l for starting actinomycin D in post-molar gestational trophoblastic neoplasia developing resistance to methotrexate spares more women multi-agent chemotherapyR Cortés-Charry, L Hennah, F E M Froeling, et al.
Journal of Neuromuscular Diseases|December 11, 2023
Monitoring Nusinersen Treatment Effects in Children with Spinal Muscular Atrophy with Quantitative Muscle MRILouise A M Otto, M Froeling, Ruben P A van Eijk, et al.
European Radiology|July 17, 2012
Evaluation of the female pelvic floor in pelvic organ prolapse using 3.0-Tesla diffusion tensor imaging and fibre tractographyF M Zijta, M M E Lakeman, M Froeling, et al.
Plos One|December 7, 2013
RhoC interacts with integrin α5β1 and enhances its trafficking in migrating pancreatic carcinoma cellsNingfeng Fiona Li, Emilios Gemenetzidis, Francis J Marshall, et al.
British Journal of Cancer|February 23, 2019
Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumoursFieke E M Froeling, Ramya Ramaswami, Panagiotis Papanastasopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2021
Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-AnalysisRaffaella Casolino, Salvatore Paiella, Danila Azzolina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2019
Bioactivation of Napabucasin Triggers Reactive Oxygen Species-Mediated Cancer Cell DeathFieke E M Froeling, Manojit Mosur Swamynathan, Astrid Deschênes, et al.
Nature Communications|September 25, 2020
Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancerHemant M Kocher, Bristi Basu, Fieke E M Froeling, et al.
Nature Communications|March 3, 2026
Clonal evolutionary analysis reveals patterns of malignant transformation of Intraductal Papillary Mucinous Neoplasms of the pancreasAntonio Pea, Xiaotong He, Rosie Upstill-Goddard, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 17, 2024
Perspectives of the medical oncologist regarding adjuvant chemotherapy for pancreatic cancer: An international expert survey and case vignette studyN C Biesma, M U J E Graus, G A Cirkel, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
ESMO Open|April 12, 2021
Increasing the human chorionic gonadotrophin cut-off to ≤1000 IU/l for starting actinomycin D in post-molar gestational trophoblastic neoplasia developing resistance to methotrexate spares more women multi-agent chemotherapyR Cortés-Charry, L Hennah, F E M Froeling, et al.
Journal of Neuromuscular Diseases|December 11, 2023
Monitoring Nusinersen Treatment Effects in Children with Spinal Muscular Atrophy with Quantitative Muscle MRILouise A M Otto, M Froeling, Ruben P A van Eijk, et al.
European Radiology|July 17, 2012
Evaluation of the female pelvic floor in pelvic organ prolapse using 3.0-Tesla diffusion tensor imaging and fibre tractographyF M Zijta, M M E Lakeman, M Froeling, et al.
Plos One|December 7, 2013
RhoC interacts with integrin α5β1 and enhances its trafficking in migrating pancreatic carcinoma cellsNingfeng Fiona Li, Emilios Gemenetzidis, Francis J Marshall, et al.
British Journal of Cancer|February 23, 2019
Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumoursFieke E M Froeling, Ramya Ramaswami, Panagiotis Papanastasopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2021
Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-AnalysisRaffaella Casolino, Salvatore Paiella, Danila Azzolina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2019
Bioactivation of Napabucasin Triggers Reactive Oxygen Species-Mediated Cancer Cell DeathFieke E M Froeling, Manojit Mosur Swamynathan, Astrid Deschênes, et al.
Nature Communications|September 25, 2020
Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancerHemant M Kocher, Bristi Basu, Fieke E M Froeling, et al.
Nature Communications|March 3, 2026
Clonal evolutionary analysis reveals patterns of malignant transformation of Intraductal Papillary Mucinous Neoplasms of the pancreasAntonio Pea, Xiaotong He, Rosie Upstill-Goddard, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 17, 2024
Perspectives of the medical oncologist regarding adjuvant chemotherapy for pancreatic cancer: An international expert survey and case vignette studyN C Biesma, M U J E Graus, G A Cirkel, et al.
Pageof 6